Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 48,476.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 441.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -408.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,297.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 2,738.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,738.00 |
| Dec 31, 2025 | 8,672.00 |
| Sep 30, 2025 | 15,104.00 |
| Jun 30, 2025 | 10,822.00 |
| Mar 31, 2025 | 8,194.00 |
| Dec 31, 2024 | 41,090.00 |
| Sep 30, 2024 | -631.00 |
| Jun 30, 2024 | 5,131.00 |
| Mar 31, 2024 | -1,982.00 |
| Dec 31, 2023 | -7,407.00 |
| Sep 30, 2023 | -7,804.00 |
| Jun 30, 2023 | -18,859.00 |
| Mar 31, 2023 | 16,401.00 |
| Dec 31, 2022 | 10,804.00 |
| Sep 30, 2022 | 17,353.00 |
| Jun 30, 2022 | 23,310.00 |
| Mar 31, 2022 | 34,140.00 |
| Dec 31, 2021 | 38,970.00 |
| Sep 30, 2021 | 65,096.00 |
| Jun 30, 2021 | 27,110.00 |
| Mar 31, 2021 | -42,030.00 |
| Dec 31, 2020 | 463,804.00 |
| Sep 30, 2020 | 3.99 Mn |
| Dec 31, 2019 | 142.48 Mn |
| Sep 30, 2019 | 5.80 Mn |
| Jun 30, 2019 | 33.44 Mn |